The reported statements, read against the company's own industry.
Financials view
Market Capitalization
273.98MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue (TTM)
3.99BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Profit Margin
-7.17%
Updated Oct 27, 2026
Beta
2.29x
vs all stocks
Updated Oct 27, 2026
52-Week Change
-46.09%
vs all stocks
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Market Capitalization
273.98MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Enterprise Value
5.87BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward P/E
-4.54x
Updated Oct 27, 2026
Price to Sales (TTM)
0.0687x
Updated Oct 27, 2026
Enterprise to Revenue
1.47x
Updated Oct 27, 2026
Enterprise to EBITDA
10.63x
Updated Oct 27, 2026
Gross Margin
59.01%
Updated Oct 27, 2026
Profit Margin
-7.17%
Updated Oct 27, 2026
Operating Margin
3.63%
Updated Oct 27, 2026
Return on Assets (TTM)
2.63%
Updated Oct 27, 2026
Revenue (TTM)
3.99BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue per Share (TTM)
25.55USDUpdated Oct 27, 2026
Quarterly Revenue Growth
4.70%
Updated Oct 27, 2026
Gross Profit (TTM)
2.34BUSD
vs all stocks (USD)
Updated Oct 27, 2026
EBITDA (TTM)
544.62MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Net Income (TTM)
-285.77MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Quarterly Earnings Growth (YoY)
4.67%
Updated Oct 27, 2026
Operating Cash Flow (TTM)
119.05MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Levered Free Cash Flow (TTM)
191.22MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Payout Ratio
0.00%
Updated Oct 27, 2026
Minority Interest (Equity)
4.63MUSDFY2025 · Dec 31, 2025
Revenue
3.86BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.61BUSDFY2025 · Dec 31, 2025
Gross Profit
2.25BUSDFY2025 · Dec 31, 2025
Operating Income
193.27MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-473.68MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-1.79MUSDFY2025 · Dec 31, 2025
Net Income
-471.89MUSDFY2025 · Dec 31, 2025
EBIT
-71.15MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
547.41MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
1.69BUSDFY2025 · Dec 31, 2025
Other Operating Expenses
10.63MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
402.54MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-3.15USDFY2025 · Dec 31, 2025
EPS (Diluted)
-3.15USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
150.16MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
150.16MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-471.89MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
-979.00KUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-170.67MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-252.34MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
270.92MUSDFY2025 · Dec 31, 2025
Income Tax Paid
16.33MUSDFY2025 · Dec 31, 2025
Interest Paid
361.18MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-471.89MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
360.05MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-16.21MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
19.55MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
-138.99MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
16.78MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
18.60MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
41.44MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-81.67MUSDFY2025 · Dec 31, 2025
Sale of Investments
1.66MUSDFY2025 · Dec 31, 2025
Other Investing Activity
13.78MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-66.24MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
100.00MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-112.36MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-2.95MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-15.31MUSDFY2025 · Dec 31, 2025
Shares Outstanding
154.75MSharesUpdated Oct 27, 2026
Float Shares
144.72MSharesUpdated Oct 27, 2026
Shares Short
5.49MSharesUpdated Oct 27, 2026
Short Ratio
8.38days
vs all stocks
Updated Oct 27, 2026
Short % of Shares Outstanding
6.47%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 3.55%.Updated Oct 27, 2026
% Held by Insiders
6.79%
vs all stocks
Updated Oct 27, 2026
% Held by Institutions
88.86%
vs all stocks
Updated Oct 27, 2026
Total Cash (MRQ)
174.44MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Cash per Share (MRQ)
1.10USDUpdated Oct 27, 2026
Total Debt (MRQ)
5.76BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Current Ratio (MRQ)
1.41x
Updated Oct 27, 2026
Book Value per Share (MRQ)
-12.69USDUpdated Oct 27, 2026
Total Assets
5.13BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.46BUSDFY2025 · Dec 31, 2025
Total Liabilities
6.95BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
3.67BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
5.99BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
967.42MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
270.92MUSDFY2025 · Dec 31, 2025
Accounts Receivable
959.45MUSDFY2025 · Dec 31, 2025
Accounts Payable
271.43MUSDFY2025 · Dec 31, 2025
Short-term Debt
134.40MUSDFY2025 · Dec 31, 2025
Deferred Revenue
190.19MUSDFY2025 · Dec 31, 2025
Long-term Debt
5.65BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
245.06MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
153.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-4.81BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
-1.83BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
12.22MUSDFY2025 · Dec 31, 2025
52-Week Low
1.38USDUpdated Oct 27, 2026
52-Week High
6.56USDUpdated Oct 27, 2026
52-Week Change
-46.09%
vs all stocks
Updated Oct 27, 2026
Beta
2.29x
vs all stocks
Updated Oct 27, 2026
50-Day MA
2.33USDUpdated Oct 27, 2026
200-Day MA
3.46USDUpdated Oct 27, 2026
Avg 10-Day Volume
804.94KSharesUpdated Oct 27, 2026
Avg 30-Day Volume
788.05KSharesUpdated Oct 27, 2026
Diluted EPS (TTM)
-1.82USDUpdated Oct 27, 2026
Other Income / Expense
-264.42MUSDFY2025 · Dec 31, 2025
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.59Profit Margin: -0.07
Supply Chain
Upstream position: supplies 4 industries, depends on 2Notable
Outgoing: 4.00Incoming: 2.00
Scale
Revenue is $3.99B, above the global median of $562.3MNotable
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And DrawdownWithin or Near the Altman Distress Zone
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And DrawdownWithin or Near the Altman Distress Zone
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And DrawdownWithin or Near the Altman Distress Zone